Newsletters

In the formulation of ADC preclinical integrated research plan, Medicilon has in-depth communication with customers. The backbone of scientific research has combined the characteristics of each case with years of practical experience and technical accumulation, and carefully submitted high-quality experimental plans and results to customers.

Medicilon nucleic acid drug R&D platform is an integrated and comprehensive solution that covers drug discovery, CMC and preclinical research services. Based on a rigorous scientific attitude, an open-minded scientific spirit and advanced equipment, our integrated solution can meet the industry's research and development needs for cutting-edge innovative nucleic acid drugs, and undertake research programs like nucleic acid drug discovery, screening and preclinical research services for pharmaceutical companies and scientific research institutions.

Medicilon has established a one-stop research platform for the preclinical R&D of Cell & Gene immunotherapies, covering a variety of immunotherapy methods including CAR-T, TCR-T and CAR-NK.

Medicilon offers a professional formulation technology platform, keeping up with the pace of innovation in drug research and development, and meeting the diverse requirements of our clients.

In order to express our appreciation for our clients for trust and support, Medicilon launched the colorful SUMMER EVENTS, involving pharmacokinetics services for drug screening (non-declaration).

Medicilon One-Stop Pharmaceutical Research CDMO is an integrated platform that combines "APIs + Preparations", and is committed to the technological innovation optimization and commercialization of global pharmaceutical processes.